Features May 2014 Issue

Study Finds Aspirin May Boost Survival in Heart Failure Patients

But the decision to start aspirin therapy should still be based on your overall health needs and your response to antiplatelet therapy.

A low-dose aspirin is a part of many heart disease patientsí daily routines. However, aspirin therapy for heart failure (HF) patients remains a somewhat controversial approach. If an HF patient is at a high risk for blood clots and heart attack, aspirin therapy may be appropriate. But not all HF patients have underlying coronary disease. And there are other concerns that aspirin interferes with prostaglandins, which are substances in the body that, among other functions, maintain healthy blood flow through the kidneys.

To continue reading this article you must be a paid subscriber.

Subscribe to Heart Advisor

Get the next year of HEART ADVISOR for just $20. That's a savings of $19 off the regular rate.

With your paid subscription you will receive unlimited access to all of our online content. That is over a decade of previous issues from Cleveland Clinic, the hospital rated #1 in cardiac care by U.S. News & World Report - free of charge.

Subscriber Log In

Forgot your password? Click Here.

Already subscribe but haven't registered for all the benefits of the website? Click here.